Previous Close | 0.1605 |
Open | 0.1410 |
Bid | 0.1415 x N/A |
Ask | 0.1795 x N/A |
Day's Range | 0.1410 - 0.1605 |
52 Week Range | 0.1200 - 0.5320 |
Volume | |
Avg. Volume | 6,359 |
Market Cap | 18.838M |
Beta (5Y Monthly) | 0.66 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0400 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
VANCOUVER, BC / ACCESSWIRE / October 7, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to announce that Terry Lynch has joined the BioNxt team as a capital markets advisor. Mr. Lynch brings ...
VANCOUVER, BC / ACCESSWIRE / September 26, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to provide an update on its flagship sublingual Cladribine drug formulation program for the treatment ...